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Background and purpose: To assess dynamic cerebral autoregulation (CA) in patients with
acute ischaemic stroke of undetermined aetiology, within 72 h of stroke onset.
Materials and methods: In 6 patients with ischaemic stroke of undetermined aetiology (aged
66  9 years, National Institutes of Health Stroke Scale [NIHSS] score on admission: 4.0,
range: 4–11), selected based on screening of 118 consecutive ischaemic stroke patients and in
14 volunteers (aged 62  10 years), we continuously monitored RR intervals (RRI), mean
arterial pressure (MAP) by means of photoplethysmography, mean cerebral blood ﬂow
velocity (CBFV) using transcranial Doppler ultrasonography, end-tidal CO2 (ETCO2) and
respiration during 2-min deep breathing paced at 6 min1 (0.1 Hz). To assess CA, we
evaluated the impact of breathing-induced MAP oscillations on ﬂuctuations of CBFV in
the hemispheres with stroke, the non-involved hemispheres and randomly selected hemi-
spheres of controls by applying cross-spectral analysis and calculating coherence, transfer
function gain (CBFV–MAP gain) and phase shift angle between the two oscillating signals.
Results: Phase shift angle between MAP and CBFV oscillations showed values >0 and was
signiﬁcantly reduced in the hemispheres without stroke as compared to controls (0.39  0.95
vs. 1.59  0.33 rad, p = 0.015), whereas in the hemispheres with stroke, phase shift angle did
not differ signiﬁcantly from that observed in the control hemispheres. Clinical status of
stroke patients signiﬁcantly improved at discharge from the hospital (NIHSS: 2.0, range: 1–8,
p = 0.028).
Conclusions: During the ﬁrst days of ischaemic stroke of undetermined aetiology, dynamic
cerebral autoregulation is compromised in the non-affected hemisphere, but not in the
hemisphere with ischaemic lesion.
# 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
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Cerebral ischaemic stroke is a leading cause of disability
worldwide [1,2]. There are multiple well established risk
factors for stroke such as age, hypertension, diabetes mellitus,
heart diseases, atherosclerosis, cigarette smoking, previous
occurrence of stroke and many other medical or behavioural
conditions [1,2].
However, precise mechanisms leading to occurrence of
stroke at a particular time in individual persons at risk still
remain largely unknown, although several factors that may
trigger a stroke have been identiﬁed. Yet, because of large
heterogeneity of risk factors for stroke and potential stroke
triggers, it is difﬁcult to precisely determine, which mecha-
nisms are mostly involved in the development of index
cerebral infarction in different patients.
Maintenance of appropriate cerebral blood ﬂow is largely
dependent on preserved cerebral autoregulation (CA) involv-
ing metabolic, myogenic and cardiovascular autonomic,
mainly sympathetic, mechanisms [3–5]. These mechanisms
are responsible for maintenance of relatively stable cerebral
blood ﬂow despite changes in systemic blood pressure [3–5].
Therefore, it seems possible that impairment of CA may
play a crucial role in the development of stroke, especially in
conditions facilitating cerebral ischaemia such as metabolic
disturbances or blood pressure ﬂuctuations accompanying, e.
g. intense emotions, rapid changes in body posture or
occurring upon arousal from sleep [1,6–9]. Compromised CA
has already been described in ischaemic stroke, particularly in
patients with severe or moderate stroke of various aetiology
[10–14]. However, it is still not clear whether an impairment of
CA contributes to the occurrence of stroke or if CA becomes
compromised as a result of stroke itself [13], especially that in
some studies, CA impairment was demonstrated also in the
non-affected hemispheres [10–12]. Such bilateral CA dysfunc-
tion, described in patients with lacunar stroke [12], was
suggested to actually precede and participate in the patho-
genesis of strokes due to small vessel disease [12].
Nonetheless, still, in approximately 30% of ischaemic stroke
cases, it is not possible to establish its aetiology, even in the
presence of speciﬁc risk factors [1,7]. Considering the fact that
older age and diseases affecting the cardiovascular system are
frequently associated with arterial and endothelial pathology,
including cerebral resistance vessels [1,7], it seems possible that
CA may be compromised in such states and may be not
sufﬁciently effective in preventing cerebral blood ﬂow decreases
in conditions known to predispose to cerebral ischaemia [1,6].
Therefore, the aim of our study was to assess cerebral
autoregulation in the affected and non-affected brain hemi-
spheres of patients with hemispheric cerebral ischaemic
stroke of undetermined aetiology.
2. Materials and methods
2.1. Study participants
One hundred eighteen patients with ischaemic stroke, diag-
nosed according to WHO criteria [15] admitted to the StrokeUnit at our Department of Neurology were screened for the
study.
Risk factors proﬁle, clinical features and results of diagnostic
tests were assessed in the stroke patients. The latter included
cranial computed tomography (CT), magnetic resonance imag-
ining (MRI), extracranial arterial and transcranial Doppler
ultrasound examination, transthoracic/transoesophageal
echocardiography, intracranial/extracranial CT angiography,
and/or angiography, electrocardiography (ECG), 24 h Holter
(ECG) monitoring and blood tests for hypercoagulability, where
indicated. We excluded 74 patients, in whom the aetiology of
ischaemic stroke was established; according to TOAST (Trial of
Org 10172 in Acute Stroke Treatment) criteria, they were
classiﬁed as strokes due to large vessel disease, strokes due
to small vessel disease, strokes due to cardioembolism, strokes
due to other causes (e.g. vasculitis, coagulation disorder) or
concurrent origin [16]. In addition, subjects with incomplete
diagnostic procedures required for the TOAST criteria (21 cases)
or admitted to the Stroke Unit beyond 48 h after stroke onset,
were also excluded from the study (13 cases).
Consequently, we selected a study group of 10 patients with
ischaemic stroke of undetermined aetiology. In 3 subjects,
there was an inadequate acoustic window and one patient was
not able to follow the breathing pattern included in the study
protocol. Finally, we analysed the data of 6 patients; 2 women
and 4 men, aged 66  9 (mean  standard deviation [SD]) years
with acute stroke of undetermined aetiology localised in the
middle cerebral artery territory; 3 patients had lesions in the
left and 3 in the right hemisphere (Table 1). After admission to
the hospital and on discharge, stroke severity was quantiﬁed
by means of National Institutes of Health Stroke Scale (NIHSS).
Within the stroke group, hypertension was present in 4
patients (66%), hypercholesterolaemia in 3 (50%), ischaemic
heart disease in 2 (33%), hypothyroidism (in euthyreotic state)
was present in one patient and diabetes mellitus in another
one. Detailed clinical characteristics of the patients are listed
in Table 1.
The control group comprised 14 age-matched volunteers; 7
women and 7 men, aged 62  10 (mean  SD) years, with no
history of stroke or other cerebrovascular disease. To determine
the effects of the stroke itself on cerebral autoregulation, in our
control group, we included persons with diseases and medica-
tion affecting the cardiovascular system similarly as concomi-
tant diseases and medication in the stroke patients, such as:
hypertension (43%), hypercholesterolaemia (29%), hypothyroid-
ism (in euthyreotic state) or ischaemic heart disease in one
patient. Detailed individual data are presented in Table 2.
Each participant was asked not to drink coffee, strong tea,
or alcohol and not to smoke cigarettes within 6 h prior to the
examination. All procedures were approved by the local ethics
committee and written informed consent was obtained from
each subject prior to testing, according to the Declaration of
Helsinki.
2.2. Protocol and measurements
The patients were studied within 72 h following the ﬁrst
clinical signs of stroke. The study took place during morning
hours in a dedicated research room kept at constant
temperature of 21 8C and constant humidity. Prior to the
Table 1 – Clinical characteristics of the patients with stroke.
Gender Age
[years]
Stroke localisation Infarct
maximum
diameter [cm]
NIHSS score
(admission;
discharge)
Concomitant
diseases
Current drug use
1 M 54 Left fronto-temporo-parietal
area, putamen and head of
the caudate
2.41 11; 8 – ASA
2 F 61 Left parietal lobe 1.3 5; 1 HT, HTH ACEI, ASA,
L-thyroxine, statin
3 F 72 Left fronto-temporal area 3.8 4; 2 HCh, HT, RA ASA, BB, diuretic,
low dose steroids,
methotrexate,
PPI, statin
4 M 65 Right parietal lobe 1.09 4; 2 DM, IHD Insulin, nitrate,
statin, ticlopidine
5 M 80 Right fronto-parietal area
and posterior putamen
1.15 4; 2 HCh, HT ACEI, ASA, CCB,
diuretic, H1ant,
hydroxizine,
6 M 61 Right parietal lobe 1.29 4; 2 HCh, HT, IHD ACEI, ASA, BB,
enoxaparin, statin
F, female; M, male; NIHSS, National Institutes of Health Stroke Scale; DM, diabetes mellitus; HCh, hypercholesterolemia; HT, hypertension;
HTH, hypothyroidism; IHD, ischaemic heart disease; RA, rheumatoid arthritis; ACEI, angiotensin-converting enzyme inhibitor; ASA,
acetylsalicylic acid; BB, beta blocker; CCB, calcium channel blocker; H1ant, histamine receptor 1 antagonist; PPI, proton pump inhibitor.
Table 2 – Clinical characteristics of the control group.
Sex Age [years] Concomitant diseases Current drug use
1 F 52 – –
2 M 56 – –
3 F 77 HCh, HT, HTH ACEI, L-thyroxine, statin
4 M 58 – –
5 M 55 – –
6 M 50 HT ACEI, diuretics
7 F 57 – –
8 F 65 HCh, HT ARA, diuretics, statin
9 M 78 HT, IHD ACEI, ASA, BB, nitrates, statin, trimetazidine
10 F 61 – –
11 M 70 HCh, HT Diuretics, statin
12 M 48 HT –
13 F 67 DJD, HCh NSAID, PPI, statin
14 F 72 – –
F, female; M, male; DJD, degenerative joint disease; HCh, hypercholesterolemia; HT, hypertension; HTH, hypothyroidism; IHD, ischaemic heart
disease; ACEI, angiotensin-converting enzyme inhibitor; ARA, angiotensin II receptor antagonist; ASA, acetylsalicylic acid; BB, beta blocker;
NSAID, nonsteroidal anti-inﬂammatory drug; PPI, proton pomp inhibitor.
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approximately 40 min to ensure stabilization of their cardio-
vascular systems.
The middle cerebral arteries (MCAs) were insonated
bilaterally and mean cerebral blood ﬂow velocity (CBFV) was
measured using transcranial Doppler ultrasound (Viasys
Healthcare Inc., Madison, WI, USA). Once the MCAs had been
identiﬁed through the temporal windows and the Doppler
signal optimised by standard methods, the probes were
attached to the skull in a ﬁxed position using an adjustable
head frame. Non-invasive beat-to-beat blood pressure (BP) was
monitored by means of ﬁnger photoplethysmography (Nexﬁn
Monitor, BMEYE, B.V., Amsterdam, The Netherlands) and heart
rate (HR) was recorded continuously from precordial ECG (3
leads) (Biopac Systems, USA). Respiratory frequency was
monitored using a respiratory belt placed around the abdomen
(Biopac Systems, USA) as well as end-tidal CO2 (ETCO2) andhaemoglobin saturation with oxygen (SatO2) were monitored
by means of a capnograph and a pulse oximeter integrated
with the Biopac system.
After 40 min of rest in supine position, we recorded 10 min
of baseline measurements and then we instructed our subjects
to breathe deeply at a rate of 6 breaths per minute (5 s
inspiration, 5 s expiration), following visual and auditory
stimuli, for 2 min. The 2-min duration of the challenge
manoeuvre was selected, as spectral analysis requires that
the length of the analyzed signal be at least as long as the
longest wavelength of interest. Duration of the manoeuvre
comprised, therefore, as many as twelve such 10-s (0.1 Hz)
breathing cycles, i.e. sufﬁcient for further spectral analysis.
Oscillations in BP at frequencies up to 0.20 Hz are
dampened by the cerebral vessels, whereas higher frequency
changes pass directly to changes in cerebral blood ﬂow [14,17].
Deep breathing paced at 6 cycles per minute (0.1 Hz)
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arterial pressure (MAP) that are subsequently transmitted onto
the cerebral vessels and result in a similar 0.1 Hz variation in
CBFV. Dynamic cerebral autoregulation can be assessed by
observing the effects of changes in MAP on CBFV oscillations
by means of cross-spectral analysis. Cross-spectral analysis
enables comparison of pairs of oscillating signals when there
is sufﬁcient coherence (Coh), indicating linear coupling
between these oscillations [18].
2.3. Data analysis
Data were recorded and transferred to the computer using
Biopac MP150 module and the AcqKnowledge 4.0 software
(Biopac Systems, USA). For further analysis, 90–110-s data
segments with most stable ETCO2 and CBFV values, i.e.
following the ﬁrst 1–3 inspiration-expiration cycles, were
selected. Oscillations in RRI, MAP and CBFV were subjected to
fast Fourier transform (FFT) power spectral analysis on
overlapping windowed data segments and, subsequently,
cross-spectral analysis was conducted to assess the transfer
of oscillations in MAP onto the CBFV using a custom-made
system.
To assess the transfer of MAP oscillations onto the CBFV,
transfer function gain (MAP–CBFV gain) and phase shift angle
between MAP and CBFV signals were calculated [14,19].
Wherever needed, phase wrapping was corrected by the factor
of 2p.
Higher MAP–CBFV gain values indicate that MAP oscilla-
tions are transferred to cerebral blood ﬂow velocity oscillations
to a greater extent, which may suggest an impairment of
cerebral autoregulation [4,19]. Normally, phase shift angle
between MAP and CBFV signals is <0 indicating that CBFV
oscillations actually precede MAP oscillations thus ‘‘prepar-
ing’’ cerebral vascular bed for changes in BP and minimizing
potential unfavourable effects of BP ﬂuctuations onto cerebral
blood ﬂow. The greater the absolute value of this phase shift,
the better the autoregulation [14].
In order to avoid possible differences in cerebrovascular
resistance (CVR) and vasomotor reactivity to changes in pCO2
between the patients and controls, we normalised MAP–CBFV
gain by the participant's mean CBFV and MAP and expressedTable 3 – Mean values of the variables recorded during baselin
intervals (RRI), mean arterial pressure (MAP), mean cerebral bl
and end-tidal CO2 (ET CO2).
Patients (n = 6) 
RRI [ms] 858  21.4 
MAP [mm Hg] 90.75  5.57 
ET CO2 [mm Hg] 31.45  3.88 
Ischaemic hemispheres Non-isc
CBVF [cm s1] 27.72  5.95 
CVR [mm Hg s cm1] 4.17  0.93 
Values are means  standard error of the mean.
a Student's t-test for two independent samples.
b ANOVA.
c Jonckheere–Terpstra test.the normalised value in arbitrary units [a.u.] [19,20]. The
normalisation factor is the ratio of MAP to CBFV, which reﬂects
CVR. Therefore, the normalised MAP–CBFV gain can be used to
estimate the dynamic CBFV responses to MAP oscillations at a
given CVR value [20].
2.4. Statistical analysis
The data are presented as means  standard error of the mean
(SEM) or median and range. Due to the skewed distribution of
0.1 Hz spectral powers of MAP and CBFV, these data were
subjected to statistical analysis after logarithmic transforma-
tion. Student's t-test for independent samples was used to
compare the observed variables between the stroke patients
and the control group. NIHSS scores on admission and
discharge from the hospital were compared using the
Wilcoxon signed rank test. Mean values of CBFV, CVR during
deep breathing, 0.1 Hz CBFV spectral power, MAP–CBFV gain
and phase shift angle were compared among patients' hemi-
spheres with ischaemic lesion, patients' hemispheres without
the lesion and randomly selected hemispheres of the controls
using one-way analysis of variance (ANOVA) with Fisher least
signiﬁcant difference (LSD) post-test where a signiﬁcant p-
value was found. The rationale for random selection of one of
the control hemispheres was based on the fact that there were
no premises to conclude that there may be differences in CA
between the left and right hemisphere in persons from our
control group.
Because of non-homogeneity of variances of CVR values
obtained in the studied hemispheres at baseline, the two-sided
Jonckheere–Terpstra test was applied for the comparison of
baseline CVR among patients' hemispheres with ischaemic
lesion, patients' hemispheres without the lesion and the
control hemispheres [21]. All p-values were two-sided and
statistical signiﬁcance level was set at p < 0.05.
3. Results
Median NIHSS score assessed in stroke patients at discharge
from the hospital was signiﬁcantly lower than that on
admission (2.0, range: 1–8 vs. 4.0, range 4–11; p = 0.028).e period in stroke patients and the control group: R-R
ood flow velocity (CBFV), cerebrovascular resistance (CVR)
Controls (n = 14) p-Value
879  25.5 0.625a
84.66  3.57 0.365a
32.16  1.77 0.847a
haemic hemispheres Controls (n = 14) p-Value
26.96  2.94 34.46  4.78 0.540b
3.45  0.44 2.86  0.25 0.184c
Table 4 – Mean values of the variables recorded during 0.1 Hz paced deep breathing in stroke patients and the control group:
R-R intervals (RRI), mean arterial pressure (MAP), mean cerebral blood flow velocity (CBFV), cerebrovascular resistance
(CVR), end-tidal CO2 (ET CO2), MAP and CBFV oscillations, normalized MAP–CBFV gain and phase shift angle at 0.1 Hz.
Patients (n = 6) Controls (n = 14) p-Value
RRI [ms] 831  33.88 886  32.7 0.335a
MAP [mm Hg] 87.84  5.22 80.87  4.58 0.385a
ET CO2 [mm Hg] 30.74  3.81 29.39  2.34 0.759a
lg 0.1 Hz power of MAP [lg mm Hg2] 0.85  0.16 1.16  0.09 0.096a
Ischaemic hemispheres Non-ischaemic hemispheres Controls (n = 14) p-Value
CBVF [cm s1] 24.55  4.40 22.27  3.50 27.68  4.29 0.704b
CVR [mm Hg s cm1] 4.44  1.02 4.57  0.83 3.38  0.30 0.269b
lg 0.1 Hz power of CBFV [lg cm2 s2] 0.09  0.24 0.09  0.13 0.17  0.13 0.552b
MAP–CBFV gain normalized [a.u.] 2.06  0.57 1.76  0.43 2.02  0.27 0.874b
Phase shift angle [rad] 0.70  0.51 0.39  0.95* 1.59  0.33 0.045b
Values are mean  standard error of the mean.
a Student's t-test for two independent samples.
b ANOVA.
* p < 0.05 compared with controls, Fisher LSD post-test.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 8 ( 2 0 1 4 ) 9 1 – 9 7 95Blood oxygen saturation in all subjects during baseline and
deep breathing test was within normal limits and did not differ
between the stroke patients and controls ( p > 0.05). Mean
values of RRI, MAP and ETCO2 did not differ signiﬁcantly
between patients and controls during baseline or during 0.1 Hz
deep breathing (Tables 3 and 4). At baseline, CBFV or CVR did
not differ among patients' hemispheres with ischaemic lesion,
patients' hemispheres without the lesion and hemispheres of
the controls (Table 3).
Metronomic breathing induced similar oscillations in MAP
in the stroke patients and controls ( p = 0.096), as well as
similar CBFV oscillations in the ischaemic, non-ischaemic and
control cerebral hemispheres ( p = 0.552) (Table 4). Coherence
between 0.1 Hz oscillations in MAP and CBFV during deep
breathing was above 0.4 in all study participants. There were
no differences in MAP–CBFV gain among patients' hemi-
spheres with ischaemic lesion, hemispheres without such
lesion and control hemispheres ( p = 0.874) (Table 4).
However, phase shift angle was signiﬁcantly reduced in
the hemispheres without stroke as compared to controls
(0.39  0.95 vs. 1.59  0.33 rad, p = 0.015) and its value was
even >0, indicating that CA is compromised in theseFig. 1 – Phase shift angle between mean arterial pressure (MAP)
ischaemic hemispheres, the non-ischaemic hemispheres and th
differences from the controls are indicated by * ( p < 0.05, ANOVAhemispheres, with CBFV oscillations passively following
changes in MAP (Fig. 1). In contrast, phase shift angles
between MAP and CBFV oscillations assessed in the ischaemic
hemispheres, similarly to control hemispheres, were <0
(Table 4), indicating preserved CA, with CBFV oscillations
leading MAP ﬂuctuations.
4. Discussion
In our study, we showed that cerebral autoregulation in the
acute phase of ischaemic stroke of undetermined aetiology is
impaired in the hemisphere not affected by stroke, but not in
the hemisphere with the ischaemic focus. This was demon-
strated by reduced phase shift between MAP and CBFV
oscillations observed in the non-affected hemispheres of
patients with stroke.
This result may seem not to support previous ﬁndings of
impaired CA in the hemispheres with infarct due to large
vessel occlusion [12–14]. However, in ischaemic stroke of this
aetiology, haemodynamic disturbances of blood ﬂow in any
larger vessel are sufﬁciently pronounced to signiﬁcantly and cerebral blood flow velocity (CBFV) oscillations in the
e control group during 0.1 Hz paced breathing. Significant
 with Fisher LSD post-test).
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inﬂuence CA effectiveness [12,14]. In contrast, our patients
had only mild disability (only 1 patient had NIHSS >8 on
admission) and small ischaemic changes found in neuroim-
aging. Moreover, our ﬁndings are consistent with results of
some studies showing that CA can be intact or only
transiently impaired in patients with mild stroke [22–24].
Furthermore, evaluation of CA in stroke due to small vessel
disease, a condition underlying the majority of lacunar
strokes, demonstrated that CA can be compromised in both
hemispheres of the brain and not only in the hemisphere
affected by stroke [12]. The study by Immink et al. also
suggests that impairment of CA is likely present before
occurrence of stroke and may largely contribute to the
pathogenesis of lacunar strokes [12]. Yet, at the time of this
study, our patients did not have radiologic manifestations of
small vessel disease.
It is also not clear if CA dysfunction observed in our study
resulted from the stroke itself or if CA impairment was present
before stroke onset. The ﬁnding of impaired CA in the
hemisphere without ischaemic focus suggests that there
may have been CA abnormalities already before the occur-
rence of stroke. However, it is unclear, why CA was not
impaired in the ischaemic hemisphere. One possible explana-
tion is that prior to stroke onset, CA might have been
compromised in both hemispheres and the occurrence of
stroke in one of them elicited systemic and local mechanisms
serving to restore blood ﬂow to the ischaemic region. Such
mechanisms usually include increase in systemic BP and local
release of metabolites with vasoactive properties [25,26]. Local
vasodilation and the rise in BP may have, therefore, improved,
at least partially, cerebral haemodynamics in the affected
hemisphere. Secondly, considering that neural, mainly sym-
pathetic, control of the cerebral resistance vessels plays a
crucial role in the mechanism of dynamic CA [5,17,27–29], it
seems possible that the improvement of CA observed in our
study was at least in part mediated by sympathetic activation
associated with systemic haemodynamic changes and super-
imposed on local metabolic perturbations.
Although there is no information on whether CA was
impaired or not in our study patients before the stroke, our
ﬁndings of asymmetrical CA dynamics may suggest that
relative CA improvement might have occurred in response to
cerebral ischaemia. This observation is also supported by
results of some studies showing that bilateral impairment of
CA can occur not only in small vessel disease but also as a
result of a more severe stroke [28,29]. In our study, however,
stroke severity was quite low as was the range of local
haemodynamic disturbances. This may explain, why CA was
not compromised in the hemisphere with stroke in this study.
Nonetheless, our results do seem to be consistent with
ﬁndings of stroke-induced impairment of CA – in fact, phase
shift angle between MAP and CBFV oscillations observed in the
ischaemic hemispheres, although not signiﬁcantly different
from that of controls, did show a tendency to smaller values.
One of limitations of this study is the small number of
patients. However, our goal was to include only such
ischaemic stroke patients, in whom the cause of stroke could
not be found despite use of all the recommended laboratory
studies. Therefore, we did not include those patients withunknown stroke aetiology, where not all the diagnostic
procedures required for TOAST classiﬁcation were performed.
Considering also the fact that our patients were selected from
quite a large number of over one hundred consecutive patients
with ischaemic stroke, it seems that our study participants do
constitute quite a uniform group, where the course of stroke
was affected mainly by changes in cerebrovascular autoregu-
lation.
Concomitant cardiovascular diseases, such as hyperten-
sion, may be associated with CA disturbances. However, it is
unlikely that they signiﬁcantly affected our results, as the
number of cardiovascular diseases was similar between the
patients and persons from the control group. To avoid any bias
in our study, we included such patients, as they represented
quite a typical population susceptible to stroke.
5. Conclusions
To our knowledge, this is the ﬁrst study to demonstrate that in
mild ischaemic stroke of undetermined aetiology, CA is
compromised only in the not affected hemisphere.
Furthermore, dynamic CA can be relatively improved in the
ischaemic hemisphere and this might be associated with
better outcome, as stroke severity at discharge from the
hospital was markedly improved in our patients. Moreover,
our ﬁndings may also suggest that impairment of dynamic
cerebral autoregulation may play an important role in the
pathomechanism of at least some ischaemic strokes of
undetermined aetiology.
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